nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials?
|
Silverberg, Jonathan I. |
|
|
|
12 |
p. 3019-3029 |
artikel |
2 |
Application and Comparison of Dermoscopy and Reflectance Confocal Microscopy in the Target Treatment of Genital Lichen Sclerosus: A Single-Arm Prospective Study
|
Bao, Chengbei |
|
|
|
12 |
p. 3071-3084 |
artikel |
3 |
A Response to: Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
|
Armstrong, April W. |
|
|
|
12 |
p. 2867-2870 |
artikel |
4 |
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
|
Drakos, Anastasia |
|
|
|
12 |
p. 2715-2730 |
artikel |
5 |
Artificial Intelligence in Dermatology: Challenges and Perspectives
|
Liopyris, Konstantinos |
|
|
|
12 |
p. 2637-2651 |
artikel |
6 |
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
|
Fasseeh, Ahmad N. |
|
|
|
12 |
p. 2653-2668 |
artikel |
7 |
Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
|
Kamińska-Winciorek, Grażyna |
|
|
|
12 |
p. 2851-2862 |
artikel |
8 |
Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
|
Senna, Maryanne M. |
|
|
|
12 |
p. 3209-3220 |
artikel |
9 |
Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
|
Shao, Shuai |
|
|
|
12 |
p. 2627-2635 |
artikel |
10 |
Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study
|
Nguyen, Hao Trong |
|
|
|
12 |
p. 3193-3208 |
artikel |
11 |
Correction to: Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study
|
Šíma, Petr |
|
|
|
12 |
p. 2871 |
artikel |
12 |
Current and Emerging Therapies in Pediatric Atopic Dermatitis
|
Johnson, Hadley |
|
|
|
12 |
p. 2691-2703 |
artikel |
13 |
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS)
|
Silverberg, Jonathan I. |
|
|
|
12 |
p. 2817-2827 |
artikel |
14 |
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
|
Paller, Amy S. |
|
|
|
12 |
p. 2839-2850 |
artikel |
15 |
Dietary Factors and Hidradenitis Suppurativa
|
Shen, Alan S. |
|
|
|
12 |
p. 3007-3017 |
artikel |
16 |
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
|
Silverberg, Jonathan I. |
|
|
|
12 |
p. 2731-2746 |
artikel |
17 |
Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial
|
Tsai, Tsen-Fang |
|
|
|
12 |
p. 3097-3110 |
artikel |
18 |
Efficacy of Avène Hydrotherapy on Chronic Pruritus in Patients with Plaque Psoriasis
|
Thouvenin, Marie-Dominique |
|
|
|
12 |
p. 3137-3151 |
artikel |
19 |
Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
|
Taylor, Susan |
|
|
|
12 |
p. 3181-3191 |
artikel |
20 |
Emerging Medical Therapies in Rosacea: A Narrative Review
|
Choe, James |
|
|
|
12 |
p. 2933-2949 |
artikel |
21 |
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
|
Bratland, Åse |
|
|
|
12 |
p. 3165-3180 |
artikel |
22 |
Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics
|
Wong, Nikita S. |
|
|
|
12 |
p. 2705-2714 |
artikel |
23 |
Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
|
Pettitt, Dan |
|
|
|
12 |
p. 2863-2866 |
artikel |
24 |
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
|
Querfeld, Christiane |
|
|
|
12 |
p. 2781-2795 |
artikel |
25 |
Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)
|
Tao, Rachel E. |
|
|
|
12 |
p. 3221-3227 |
artikel |
26 |
Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin
|
Wong, Russell |
|
|
|
12 |
p. 3057-3069 |
artikel |
27 |
Multidisciplinary Rheuma–Derma Clinics: 5 Years of Experience at the San Marco Hospital in Catania
|
Foti, Rosario |
|
|
|
12 |
p. 2829-2837 |
artikel |
28 |
New Developing Treatments for Molluscum Contagiosum
|
Lacarrubba, Francesco |
|
|
|
12 |
p. 2669-2678 |
artikel |
29 |
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
|
Blauvelt, Andrew |
|
|
|
12 |
p. 3031-3042 |
artikel |
30 |
Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
|
Lockshin, Benjamin |
|
|
|
12 |
p. 2797-2815 |
artikel |
31 |
Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
|
Jing, Shan |
|
|
|
12 |
p. 3153-3164 |
artikel |
32 |
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries
|
Vañó-Galván, Sergio |
|
|
|
12 |
p. 3121-3135 |
artikel |
33 |
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials
|
Katoh, Norito |
|
|
|
12 |
p. 2765-2779 |
artikel |
34 |
Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data
|
Pivneva, Irina |
|
|
|
12 |
p. 2747-2763 |
artikel |
35 |
Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
|
Luna, Paula C. |
|
|
|
12 |
p. 3043-3055 |
artikel |
36 |
Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions
|
Koumaki, Dimitra |
|
|
|
12 |
p. 3229-3239 |
artikel |
37 |
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
|
Menter, Alan |
|
|
|
12 |
p. 2929-2932 |
artikel |
38 |
The Benefits of a Multimechanistic Antiaging Skin Technology
|
Draelos, Zoe Diana |
|
|
|
12 |
p. 3111-3119 |
artikel |
39 |
The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation
|
Coetzee, Skyler |
|
|
|
12 |
p. 2993-3006 |
artikel |
40 |
The Impact of Global Health Disparities on Atopic Dermatitis in Displaced Populations: Narrowing the Health Equity Gap for Patients with Skin of Color
|
Jelousi, Sami |
|
|
|
12 |
p. 2679-2689 |
artikel |
41 |
Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
|
Egeberg, Alexander |
|
|
|
12 |
p. 2951-2991 |
artikel |
42 |
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
|
Schleicher, Stephen |
|
|
|
12 |
p. 3085-3096 |
artikel |